1.
|
13 p, 1.2 MB |
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy : A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
/
Schoettler, M.L. (Children's Healthcare of Atlanta) ;
Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Cho, Byung-Sik (The Catholic University of Korea) ;
Dandoy, Christopher E. (Cincinnati Children's Hospital Medical Center) ;
Ho, Vincent Trien Vinh (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Jodele, Sonata (Cincinnati Children's Hospital Medical Center) ;
Moissev, I. (Pavlov First Saint Petersburg State Medical University) ;
Sańchez Ortega, Isabel (European Society for Bone Marrow Transplant) ;
Srivastava, Alok (Christian Medical College Vellore) ;
Atsuta, Yoshiko (Aichi Medical University) ;
Carpenter, Paul A. (Seattle Children's Hospital) ;
Koreth, John (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Kröger, Nicolaus M. (Ohio State. University) ;
Ljungman, Per (Karolinska Institutet (Estocolm, Suècia)) ;
Page, Kristin M. (Medical College of Wisconsin) ;
Popat, Uday R. (The University of Texas MD Anderson Cancer Center) ;
Shaw, Bronwen E. (Medical College of Wisconsin) ;
Sureda Balari, Anna Maria (Institut Catala d'Oncologia-Hospital Duran i Reynals) ;
Soiffer, Robert J. (Dana-Farber Cancer Institute (Estats Units d'Amèrica)) ;
Vasu, Sumithira V. (Ohio State. University)
Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of hematopoietic cell transplantation (HCT) associated with significant morbidity and mortality. [...]
2023 - 10.1016/j.jtct.2022.11.015
Transplantation and Cellular Therapy, Vol. 29 Núm. 3 (march 2023) , p. 151-163
|
|
2.
|
13 p, 1.6 MB |
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8
/
Toribio-Castelló, Sofía (CIBERONC. Research Group CB16/12/00233) ;
Castaño-Díez, Sandra (Hospital Clínic i Provincial de Barcelona) ;
Villaverde-Ramiro, Ángela (Universidad de Salamanca) ;
Such, Esperanza (Hospital Universitari i Politècnic La Fe (València)) ;
Arnán, Montserrat (Hospital Duran i Reynals (Hospitalet del Llobregat)) ;
Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Díaz-Beyá, Marina (Hospital Clínic i Provincial de Barcelona) ;
Díez-Campelo, María (CIBERONC. Research Group CB16/12/00233) ;
del Rey, Mónivs (Hospital Universitario de Salamanca) ;
González, Teresa (Hospital Universitario de Salamanca) ;
Hernández-Rivas, Jesús María (CIBERONC. Research Group CB16/12/00233)
Trisomy 8 (+8) is the most frequent trisomy in myelodysplastic syndromes (MDS) and is associated with clinical heterogeneity and intermediate cytogenetic risk when found in isolation. The presence of gene mutations in this group of patients and the prognostic significance has not been extensively analyzed. [...]
2023 - 10.3390/cancers15153822
Cancers, Vol. 15 Núm. 15 (august 2023) , p. 3822
|
|
3.
|
26 p, 520.5 KB |
Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis
/
Lobato-Delgado, Barbara (Institut d'Investigació Biomèdica Sant Pau) ;
Priego-Torres, Blanca (Instituto de Investigación e Innovación Biomédica de Cádiz) ;
Sanchez-Morillo, Daniel (Instituto de Investigación e Innovación Biomédica de Cádiz)
Cancer is one of the most detrimental diseases globally. Accordingly, the prognosis prediction of cancer patients has become a field of interest. In this review, we have gathered 43 state-of-the-art scientific papers published in the last 6 years that built cancer prognosis predictive models using multimodal data. [...]
2022 - 10.3390/cancers14133215
Cancers, Vol. 14 Núm. 13 (July 2022) , p. 3215
|
|
4.
|
12 p, 1.5 MB |
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy : external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
/
Jordà, Paloma (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Bosman, Laurens P. (Division of Heart and Lungs. Department of Cardiology. University Medical Center Utrech. Utrecht University) ;
Gasperetti, Alessio (Division of Cardiology. Department of Medicine. Johns Hopkins Hospital) ;
Mazzanti, Andrea (Centro Nacional de Investigaciones Cardiovasculares. Department of Molecular Cardiology) ;
Gourraud, Jean Baptiste (Department of Cardiology. Centre Hospitalier Universitaire Nantes) ;
Davies, Brianna (Centre for Cardiovascular Innovation. Division of Cardiology. University of British Columbia) ;
Frederiksen, Tanja Charlotte (Department of Clinical Medicine Health. Aarhus University) ;
Moreno Weidmann, Zoraida (Institut d'Investigació Biomèdica Sant Pau) ;
Di Marco, Andrea (Hospital Universitari de Bellvitge. Unitat d'Arrítmies. Servei de Cardiologia) ;
Roberts, Jason D. (Section of Cardiac Electrophysiology. Division of Cardiology. Department of Medicine. Western University) ;
Macintyre, Ciorsti (Cardiac Electrophysiology Service. Quenn Elisabeth II Health Sciences Center. Dalhousie University) ;
Seifer, Colette (St-Boniface Hospital. University of Manitoba) ;
Delinière, Antoine (National Reference Center for Inherited Arrhythmias of Lyon. Louis Pradel Cardiovascular Hospital. Hospices Civils de Lyon) ;
Alqarawi, Wael (Cardiac Electrophysiology Service. Ottawa Heart Institute. University of Ottawa) ;
Kukavica, Deni (Centro Nacional de Investigaciones Cardiovasculares. Department of Molecular Cardiology) ;
Minois, Damien (Department of Cardiology. Centre Hospitalier Universitaire Nantes) ;
Trancuccio, Alessandro (Department of Molecular Cardiology. Centro Nacional de Investigaciones Cardiovasculares) ;
Arnaud, Marine (Department of Cardiology. Centre Hospitalier Universitaire Nantes) ;
Targetti, Mattia (Cardiomyopathy Unit. Department of Cardiology. Careggi University Hospital) ;
Martino, Annamaria (Department of Cardiology. Policlinico Casilino) ;
Oliviero, Giada (Department of Cardiology. Policlinico Casilino) ;
Pipilas, Daniel C. (Cardiovascular Research Center. Cardiac Arrhythmia Service. Massachusetts General Hospital) ;
Carbucicchio, Corrado (Department of Clinical Electrophysiology. Cardiac Pacing Centro Cardiologico Monzino. IRCCSC) ;
Compagnucci, Paolo (Department of Biomedical Sciences and Public Health. Cardiology and Arrhythmology Clinic. University Hospital Umberto I-Salesi-Lancisi. Marche Polytechnic University) ;
Dello Russo, Antonio (Department of Biomedical Sciences and Public Health. Cardiology and Arrhythmology Clinic. University Hospital Umberto I-Salesi-Lancisi. Marche Polytechnic University) ;
Olivotto, Iacopo (Careggi University Hospital (Florència, Itàlia)) ;
Calò, Leonardo (Department of Cardiology. Policlinico Casilino) ;
Lubitz, Steven A. (Cardiovascular Research Center. Cardiac Arrhythmia Service. Massachusetts General Hospital) ;
Cutler, Michael J. (Intermountain Medical Center Heart Institute. Intermountain Medical Center) ;
Chevalier, Philippe (National Reference Center for Inherited Arrhythmias of Lyon. Louis Pradel Cardiovascular Hospital. Hospices Civils de Lyon) ;
Arbelo, Elena (European Reference Network for rare. low prevalence and complex diseases of the heart. ERN GUARD-Heart) ;
Priori, Silvia (Centro Nacional de Investigaciones Cardiovasculares. Department of Molecular Cardiology) ;
Healey, Jeffrey S. (Division of Cardiology. Hamilton Health Sciences) ;
Calkins, Hugh (Division of Cardiology. Department of Medicine. Johns Hopkins Hospital) ;
Casella, Michela (Department of Clinical. Special and Dental Sciences. Cardiology and Arrhythmology Clinic. University Hospital Umberto I-Salesi-Lancisi. MarchePolytechnic University) ;
Jensen, Henrik Kjærulf (Department of Clinical Medicine Health. Aarhus University) ;
Tondo, Claudio (Department of Biomedical. Surgical and Dentistry Sciences. University of Milan) ;
Tadros, Rafik (Cardiovascular Genetics Center. Montreal Heart Institute. Universite de Montreal) ;
James, Cynthia (Division of Cardiology. Johns Hopkins Hospital) ;
Krahn, Andrew D. (Centre for Cardiovascular Innovation. Division of Cardiology. University of British Columbia) ;
Cadrin-Tourigny, Julia (Cardiovascular Genetics Center. Montreal Heart Institute. Universite de Montreal) ;
Universitat Autònoma de Barcelona
Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk. [...]
2022 - 10.1093/eurheartj/ehac289
European heart journal, Vol. 43 Núm. 32 (August 2022) , p. 3041-3052
|
|
5.
|
19 p, 1.1 MB |
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer : Systematic Review on the Performance of Risk Stratification Models
/
Guerrero-Ramos, F. (Hospital Universitario 12 de Octubre (Madrid). Servicio de Urología) ;
Subiela, J.D. (Hospital Ramón y Cajal. Servicio de Urología. Instituto Ramón y Cajal de Investigación Sanitaria. Universidad De Alcalá) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Aumatell, Julia (Fundació Puigvert. Servicio de Urología) ;
Manfredi, Celeste (Unit Of Urology. Department Of Woman. Child And General And Specialized Surgery. University Of Campania 'Luigi Vanvitelli') ;
Bozzini, Giorgia (Department Of Urology. Asst Lariana Ospedale Sant'Anna) ;
Romero-Otero, Javier (Department Of Urology. Hospital Universitario Hm Sanchinarro) ;
Couñago, Felipe (Hospital La Milagrosa)
BACKGROUND: Several classifications have been reported to stratify non-muscle-invasive bladder cancer (NMIBC) in risk groups according to the probability of recurrence and progression. OBJECTIVE: To systematically review the current evidence regarding risk stratification of NMIBC. [...]
2022 - 10.3233/BLC-220055
Bladder Cancer, Vol. 8 Núm. 4 (2022) , p. 339-357
|
|
6.
|
23 p, 2.8 MB |
La incidencia de la experiencia laboral en la movilidad social intergeneracional en España
/
Fachelli, Sandra (Universidad Pablo de Olavide) ;
López-Roldán, Pedro (Universitat Autònoma de Barcelona) ;
Segura-Carrillo, Cristian (Universitat Autònoma de Barcelona)
Se presentan los resultados actualizados en el estudio de la movilidad social intergeneracional en España siguiendo los tradicionales análisis del triángulo OED (origen social, educación y destino social), en que se introduce el efecto de la experiencia laboral medida por la edad y los años trabajados, aplicando un diseño que tiene en cuenta la cohorte, el período y la edad. [...] The updated results in the study of intergenerational social mobility in Spain are presented following the traditional analysis of the OED Triangle (Social Origin, Education and Social Destiny) where the effect of work experience measured by age and years worked is introduced, applying a design that takes cohort, period, and age into account. [...]
2023 - 10.3989/ris.2023.81.2.M22b-005
Revista internacional de sociología, Vol. 81 Núm. 2 (2023) , p. e226
|
|
7.
|
10 p, 1.8 MB |
Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau européen de traîtement d'arrhythmies cardiaques)-group
/
Müller-Edenborn, Björn (Julius-Hospital (Würzburg, Alemanya)) ;
Moreno-Weidmann, Zoraida (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Venier, Sandrine (University Hospital Grenoble (França)) ;
Defaye, Pascale (University Hospital Grenoble (França)) ;
Park, Chan-il (Hôpital de La Tour (Suïssa)) ;
Guerra, José (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Alonso-Martin, Concepción (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Bazán, Víctor (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Vinolas, Xavier (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Rodriguez-Font, Enrique (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Campos, Bieito (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Boveda, Serge (Clinique Pasteur (Toulouse, França)) ;
Combes, Stéphane (Clinique Pasteur (Toulouse, França)) ;
Albenque, Jean-Paul (Clinique Pasteur (Toulouse, França)) ;
Guy-Moyat, Benoit (University Hospital Limoges) ;
Trenk, Dietmar (University of Freiburg) ;
Eichenlaub, Martin (University of Freiburg) ;
Chen, Juan (University Hospital Mainz (Alemanya)) ;
Lehrmann, Heiko (University of Freiburg) ;
Neumann, Franz-Josef (University of Freiburg) ;
Arentz, Thomas (University of Freiburg) ;
Jadidi, Amir (University of Freiburg) ;
Universitat Autònoma de Barcelona
Despite advances in interventional treatment strategies, atrial fibrillation (AF) remains associated with significant morbidity and mortality. Fibrotic atrial myopathy (FAM) is a main factor for adverse outcomes of AF-ablation, but complex to diagnose using current methods. [...]
2021 - 10.1007/s00392-021-01973-1
Clinical Research in Cardiology, Vol. 111 (december 2021) , p. 1018-1027
|
|
8.
|
|
9.
|
12 p, 1.6 MB |
Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study
/
Pérez-Fernández, Laura (Hospital del Tajo) ;
Sastre, Julia (Hospital Universitario de Toledo) ;
Zafón, Carles (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Oleaga, Amelia (Hospital de Basurto (Bilbao, Biscaia)) ;
Castelblanco, Esmeralda (Hospital Arnau de Vilanova (València)) ;
Capel Flores, Ismael (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Galofré, Juan C. (Instituto de Investigación Sanitaria de Navarra) ;
Guadalix-Iglesias, Sonsoles (Hospital Universitario 12 de Octubre (Madrid)) ;
De la Vieja, Antonio (Instituto de Salud Carlos III) ;
Riesco-Eizaguirre, Garcilaso (Universidad Francisco de Vitoria) ;
Universitat Autònoma de Barcelona
The dynamic risk stratification (DRS) is a relatively new system in thyroid cancer that considers the response to primary treatment to improve the initial risk of recurrence. We wanted to validate DRS system in a nationwide multicenter study and explore if the incorporation of BRAFV600E into DRS helps to better categorize and predict outcomes. [...]
2023 - 10.3389/fendo.2022.1071775
Frontiers in Endocrinology, Vol. 13 (january 2023)
|
|
10.
|
8 p, 435.5 KB |
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock
/
Hongisto, Mari ;
Lassus, Johan ;
Tarvasmäki, Tuukka ;
Sans-Roselló, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Tolppanen, Heli ;
Kataja, Anu ;
Jäntti, Toni ;
Sabell, Tuija ;
Banaszewski, Marek ;
Silva-Cardoso, Jose ;
Parissis, John ;
Jurkko, Raija ;
Spinar, Jindrich ;
Castrén, Maaret ;
Mebazaa, Alexandre ;
Masip, Josep ;
Harjola, Veli-Pekka ;
Universitat Autònoma de Barcelona
Soluble urokinase-type plasminogen activator receptor (suPAR) is a biomarker reflecting the level of immune activation. It has been shown to have prognostic value in acute coronary syndrome and heart failure as well as in critical illness. [...]
2022 - 10.1093/ehjacc/zuac096
European Heart Journal. Acute Cardiovascular Care, Vol. 11 (august 2022) , p. 731-738
|
|